Differences in mean number of papers (top) and co-authors (bottom) depending on (1) NI membership and (2) time joined NI. by William C. Barley (8915282)

Subjects:

Regression estimates and incidence rate ratios from GLMER for number of papers (top) and coauthors (bottom). by William C. Barley (8915282)

Subjects:

(A) Side image of epoxy resin-made abutment-analog base and prosthesis; (B) Front image of epoxy resin-made abutment-analog base and prosthesis. by Long Li (6555)

Juvenile demyelination leads to a substantial decrease in potassium currents in PV interneurons of the PFC. by Sara Hijazi (21656615)

“…I–V curves showing a significant decrease in Kv amplitude in PV interneurons from mice that underwent juvenile demyelination. …”

Everolimus decreased CD89 deposits in α1^KICD89^Tg mice. by Alexandra Cambier (22307216)

Five main steps of MATSim. by Jingfa Ma (20396406)

Flow Chart of the Study Steps. by Azam Hosseinpour (13434515)

Experimental setup. by Shinnosuke Hase (20917896)

“…Conversely, the fast-rhythm auditory guide significantly increased step rate and decreased step length (p <  0.05). …”

Placebo test. by Le Zhu (1771669)

Subjects:

Mean muscle activation patterns across the gait cycle during walking with mediolateral (ML) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke duri... by Sanne Ettema (18786312)

Mean muscle activation patterns across the gait cycle during walking with anteroposterior (AP) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke d... by Sanne Ettema (18786312)

Mean muscle activation patterns across the gait cycle during walking with Body Weight Support (BWS) for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke dur... by Sanne Ettema (18786312)

iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. by Farrokh Habibzadeh (12256529)

Fig 1 - by Farshid Maleki (20521649)

Subjects:

Fig 8 - by Farshid Maleki (20521649)

Subjects:

Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells. by Farshid Maleki (20521649)

Subjects:

Fig 4 - by Farshid Maleki (20521649)

Subjects:

Fig 9 - by Farshid Maleki (20521649)

Subjects:

Trypan blue dye exclusion assay for cell viability evaluation (% of control). by Farshid Maleki (20521649)

Subjects: